All performance/activity data used in this document refers to the latest information available at the time.
The COO Report, Operational Service Report (August and September Data), Performance Profile (August and September Data), National Performance Oversight Group Meeting Notes (August and September Data), the Winter PMO Report, and the Scheduled Care Report which had been circulated prior to the meeting were noted. Both August and September Data was circulated to the Committee as the October meeting of the Committee was postponed.
The COO updated the Committee on the key operational pieces outlined in the above documents. In relation to vaccination, he advised the Committee that although the uptake of flu vaccines is good overall, the uptake of Covid-19 vaccine boosters among healthcare workers is low. The COO confirmed that there will be better data available on this issue in January but uptake rates are concerning currently. He advised the Committee that work is ongoing to make these vaccines as accessible as possible to both healthcare workers and vulnerable people.
While considering the data presented on un-scheduled care, the Committee discussed the definitions for unscheduled care and scheduled care and the importance of being able to compare data year-on-year. Regarding scheduled care incorporating information across many specialties, the Committee felt it is difficult to get a sense of true performance by specialty at macro level. The COO confirmed improvement on waiting list year to date
The Committee discussed how communication to the public in being managed in a number of areas and suggested it should be improved in relation to improvements on waiting lists. The COO advised that this is currently being examined and emphasising good performance of services would also be beneficial for HSE staff. It was also highlighted that the positives of working for the HSE are not publicised enough which may impact recruitment and retention and it was agreed that this issue should be examined by the People and Culture Committee in future.
The COO highlighted that in relation to primary care therapies, the workforce has grown significantly though recruitment challenges do remain. He confirmed that work is underway to make some roles more desirable Work is also in progress by National HR with the DOH to increase the intake of trainees, albeit if agreed it will be some years before the benefit will be seen in the workforce. ND Community Operations highlighted that a consistent trend emerging from analysis is that additional administrative staff would have a significant positive impact on clinicians time, freeing up roughly 20%.
In relation to cancer services, the Committee queried whether there are challenges in accessing private diagnostic capacity, as this is considered a safety net of the public system currently. AND Acute Operations confirmed that the HSE has had access to private diagnostic services in recent months and this will come to an end soon but that does not stop access in certain areas e.g. emergency care.
Following questions from the Committee, AND Acute Operations advised that significant staffing challenges can be seen in midwifery, more so than nursing generally. He confirmed that international recruitment drives are currently underway but it remains a significant pressure point in the system. Despite work underway in this area, it is expected to remain an issue in the short term. Recognising that there are many outside challenges, such as difficulty securing accommodation, which impact the HSE’s recruitment efforts, the Committee highlighted that the HSE needs to focus on improving what is under its control.
Following a request from the Committee at its September meeting, the COO provided a verbal update on the policy and local implementation of visiting policy for family and carers in healthcare settings. AND Acute Operations highlighted that revised guidelines had been received from the HPSC in August which now replace previous guidance. He advised that the system has been surveyed and though there is generally daily access permitted for visitors, there is variability cognisant of local quality patient safety issues, however, the HSE is now seeking uniformity across the system to the greatest extent possible. The Committee highlighted that visitors are often part of the patients care and this should be considered in implementation of future visitors’ policy.